Dr Lavinia Spain
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
103 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
DOI: 10.1001/jamanetworkopen.2026.70302026
Journal article
[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study
DOI: 10.1016/S1470-2045(26)00017-32026
Journal article
CYTOSHRINK: A randomized phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with ipilimumab/nivolumab for metastatic kidney cancer.
DOI: 10.1200/JCO.2026.44.7_suppl.4162026
Journal article
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials
DOI: 10.1016/j.eururo.2026.03.0242025
Journal article
Patterns of recurrence after lymphadenectomy for melanoma lymph node metastasis at high risk of recurrence in the modern era of adjuvant systemic therapy.
DOI: 10.1016/j.ejso.2025.1111352025
Journal article
Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma
DOI: 10.1186/s13059-025-03812-22025
Journal article
Neuroimaging features of immune-related adverse events due to immune checkpoint inhibitor therapy
DOI: 10.1186/s13244-025-01999-3
RECENT SCHOLARLY WORKS
2025
Journal article
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors
DOI: 10.1136/jitc-2025-0118652025
Journal article
Long-term clinical outcomes of bevacizumab for treatment of stereotactic radiosurgery-induced radiation necrosis in patients with brain metastases
DOI: 10.1007/s11060-025-05121-x2025
Journal article
1694eP Real-world induction targeted therapy (TT) with immune checkpoint inhibitor (ICI) therapy switch in advanced BRAF-mutant melanoma: A multi-institutional study
DOI: 10.1016/j.annonc.2025.08.2321